ArticleClinical ophthalmology (Auckland, N.Z.)2025
Comparing Rotational Stability of Clareon and Eyhance Toric IOLs in a Real-World Setting.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Visual Outcomes and Patient Satisfaction With a New Trifocal, Toric Intraocular Lens.Journal of ophthalmology · 2026Article
- Real-World Visual Outcomes and Rotational Stability of a Monofocal Toric Intraocular Lens.Clinical ophthalmology (Auckland, N.Z.) · 2025Article
- Rotational Stability and Subjective Results of Tecnis Eyhance Toric II Intraocular Lens.Clinical ophthalmology (Auckland, N.Z.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Eyhance Toric intraocular lens (IOL) builds upon the Tecnis Toric platform, initially associated with considerable post-operative rotational instability. Version 2, the Eyhance Toric IOL has been modified to enhance rotational stability. This study evaluates the post-operative rotational stability of the Eyhance Toric IOL compared to the Clareon Toric IOL, recognized for its stable performance. Methods: Patients undergoing cataract surgery received either the Eyhance or Clareon Toric IOLs. Placement was guided by the Barrett Toric Calculator at baseline (P0). IOL stability, uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), and refractive astigmatism were assessed at 6-24 hours (P1) and 3 weeks to 6 months (P2) post-operatively. IOL rotational measurements were recorded at each interval. Results: The study included 187 patients (median age: 74 for Clareon, 79 for Eyhance, p = 0.004). No significant differences were found in UDVA, CDVA, or refractive astigmatism at P2. Median rotation from P0 to P1 (3.0 vs 4.0 degrees, p = 0.091) and P0 to P2 (1.0 vs -0.5 degrees, p = 0.482) were not statistically different. However, the Clareon IOL showed less rotation between P1 and P2 (0.0 vs 1.0 degrees, p = 0.049). Absolute rotation from P0 to P1 (4.0 degrees), P1 to P2 (1.0 vs 2.0 degrees, p = 0.064), and P0 to P2 (4.0 vs 3.5 degrees, p = 0.095) were comparable. Conclusion: The Eyhance Toric IOL demonstrated comparable rotational stability and visual outcomes to the Clareon Toric IOL. Modifications in the Eyhance design have successfully improved its rotational stability, positioning it as a viable alternative to the Clareon Toric IOL in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.